Found: 89
Select item for more details and to access through your institution.
PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 540, doi. 10.2967/jnumed.123.267042
- By:
- Publication type:
- Article
PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.267042
- By:
- Publication type:
- Article
Sequential and Combination Therapies of <sup>223</sup>RaCl<sub>2</sub> and Prostate-Specific Membrane Antigen Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1932, doi. 10.2967/jnumed.123.266427
- By:
- Publication type:
- Article
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 4, p. 1, doi. 10.2967/jnmt.122.264928
- By:
- Publication type:
- Article
A Life Study in Academic Leadership: A Conversation Between Carolyn C.Meltzer and Hossein Jadvar.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1167, doi. 10.2967/jnumed.123.266097
- By:
- Publication type:
- Article
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 1, p. 16, doi. 10.2967/jnmt.122.264928
- By:
- Publication type:
- Article
SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 149, doi. 10.2967/jnumed.122.264200
- By:
- Publication type:
- Article
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1836, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 4, p. 1, doi. 10.2967/jnmt.122.264928
- By:
- Publication type:
- Article
Management Impact of Metachronous Oligometastatic Disease Identified on <sup>18</sup>F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer.
- Published in:
- Molecular Imaging & Biology, 2022, v. 24, n. 6, p. 920, doi. 10.1007/s11307-022-01742-0
- By:
- Publication type:
- Article
Oligometastatic Prostate Cancer: Current Status and Future Challenges.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1628, doi. 10.2967/jnumed.121.263124
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264200
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264200
- By:
- Publication type:
- Article
SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2022, v. 24, n. 1, p. 1, doi. 10.1186/s12968-022-00867-z
- By:
- Publication type:
- Article
SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2022, v. 24, n. 1, p. 1, doi. 10.1186/s12968-022-00867-z
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 7, p. 2300, doi. 10.1007/s00259-022-05785-x
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
Targeted α-therapy in non-prostate malignancies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 49, n. 1, p. 47, doi. 10.1007/s00259-021-05405-0
- By:
- Publication type:
- Article
The VISION Forward: Recognition and Implication of PSMA-/FDG+ mCRPC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.263274
- By:
- Publication type:
- Article
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.263262
- By:
- Publication type:
- Article
Nuclear Medicine Textbook - Methodology and Clinical Applications.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.263612
- By:
- Publication type:
- Article
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.263262
- By:
- Publication type:
- Article
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.263262
- By:
- Publication type:
- Article
Low-count whole-body PET with deep learning in a multicenter and externally validated study.
- Published in:
- NPJ Digital Medicine, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s41746-021-00497-2
- By:
- Publication type:
- Article
Author Correction: Low-count whole-body PET with deep learning in a multicenter and externally validated study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Low-count whole-body PET with deep learning in a multicenter and externally validated study.
- Published in:
- NPJ Digital Medicine, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s41746-021-00497-2
- By:
- Publication type:
- Article
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 6, p. 1803, doi. 10.1007/s00432-020-03458-6
- By:
- Publication type:
- Article
A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical based therapy.
- Published in:
- Canadian Urological Association Journal, 2020, v. 14, n. 4, p. 130, doi. 10.5489/cuaj.6506
- By:
- Publication type:
- Article
Prediction of time to hormonal treatment failure in metastatic castrate-sensitive prostate cancer with <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223263
- By:
- Publication type:
- Article
Preclinical evaluation of a <sup>64</sup>Cu-labeled disintegrin for PET imaging of prostate cancer.
- Published in:
- Amino Acids, 2019, v. 51, n. 10-12, p. 1569, doi. 10.1007/s00726-019-02794-3
- By:
- Publication type:
- Article
Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 11, p. 1524, doi. 10.2967/jnumed.118.223263
- By:
- Publication type:
- Article
Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 1, p. 8, doi. 10.1007/s00259-018-4191-0
- By:
- Publication type:
- Article
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1338, doi. 10.2967/jnumed.118.213470
- By:
- Publication type:
- Article
Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
REPLY.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 4, p. 715, doi. 10.2967/jnumed.117.206946
- By:
- Publication type:
- Article
Non-oncologic Applications of PET/CT and PET/MR in Musculoskeletal, Orthopedic, and Rheumatologic Imaging: General Considerations, Techniques, and Radiopharmaceuticals.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PSMA PET: Transformational Change in Prostate Cancer Management?
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 2, p. 228, doi. 10.2967/jnumed.117.203604
- By:
- Publication type:
- Article
The First Theranostic Conference at the American University of Beirut Medical Center.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 13N
- By:
- Publication type:
- Article
SNMMI Scientific Delegation to Cuba.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 15N
- By:
- Publication type:
- Article
PSMA Theranostics: Current Status and Future Directions.
- Published in:
- Molecular Imaging, 2018, v. 17, p. 1, doi. 10.1177/1536012118776068
- By:
- Publication type:
- Article
Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 12, p. 2026, doi. 10.2967/jnumed.117.197988
- By:
- Publication type:
- Article
Highlights of articles published in annals of nuclear medicine 2016.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 11, p. 1928, doi. 10.1007/s00259-017-3782-5
- By:
- Publication type:
- Article
The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.
- Published in:
- Diagnostics (2075-4418), 2017, v. 7, n. 3, p. 43, doi. 10.3390/diagnostics7030043
- By:
- Publication type:
- Article
ACR and SNMMI Joint Credentialing Statement for PET/MRI of the Body.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1174, doi. 10.2967/jnumed.117.193524
- By:
- Publication type:
- Article
Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting <sup>18</sup>F-Sodium Fluoride Positron Emission Tomography-Computed Tomography Positivity for First Bone Metastases in Patients with Biochemical Recurrence after Radical Prostatectomy
- Published in:
- World Journal of Nuclear Medicine, 2017, v. 16, n. 3, p. 229, doi. 10.4103/1450-1147.207286
- By:
- Publication type:
- Article
SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 11, doi. 10.2967/jnumed.116.182584
- By:
- Publication type:
- Article